scorecardresearch
Monday, August 11, 2025
TopicBiocon

Topic: Biocon

India prepares to test Itolizumab, the drug credited for lowering Covid mortality in Cuba

The drug will go under trial in six hospitals in India, including AIIMS-Delhi, KEM Hospital in Mumbai and Narayana Health in Bengaluru. 

Biocon’s blood purification device gets regulator nod for treating critical Covid patients

CytoSorb was introduced in 2013 for Sepsis patients. It has now been allowed to treat critical Covid patients to help reduce their cytokines levels.

Made-in-India Covid-19 vaccine could be ready in a year, says Biocon’s Kiran Mazumdar-Shaw

In an interview to ThePrint, Biocon co-founder Kiran Mazumdar-Shaw says India is ahead of other countries in flattening the Covid-19 curve.

On Camera

With nuke lunacy, Asim Munir joins Pakistan’s Hall of Generals who swapped brains for bluster

Munir indicates that he’s willing to go for broke, even if it risks taking his country “and half the world” down with him. It’s important to understand where he is coming from.

How mining, manufacturing & power sectors weighed on India’s industrial output since January 2024

India’s industrial output growth saw a 10-month low in June, with Index of Industrial Production (IIP) growing by mere 1.5% as against 1.9% in May 2025.

‘Next war may come sooner than expected, will require whole-of-nation approach’—Army chief

Gen Dwivedi framed Op Sindoor not just as retaliation to Pahalgam, but as demonstration of India’s capability to fight multi-domain conflicts with integration between services & agencies.

Modi’s ready to risk it all for farmers. Farm reform can answer Trump with new Green Revolution

Standing up to America is usually not a personal risk for a leader in India. Any suggestions of foreign pressure unites India behind who they see as leading them in that fight.